SOLV · Solventum Corporation
$63.572026-05-17Sector: Healthcare; Industry: Medical - Care Facilities; Sub-Industry: Health Care Technology
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Bull
$282
+343.5% vs market
Base · active
$204
+220.9% vs market
Bear
$181
+184.5% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($181 · $282) Analysts Range ($97 · $105) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2022.Q4 | $8.1B | — | 23.5% | 24.9% | $1.4B | −$191MM | $1.2B | 6.4% | — | 65.1% | $2.2B | $7.66 | — |
| 2023.Q4 | $8.2B | 0.8% | 23.3% | 19.3% | $1.5B | $111MM | $1.7B | 5.9% | — | 12.8% | $21.9B | $7.68 | — |
| 2024.Q4 | $8.3B | 0.7% | 14.2% | 21.0% | $923MM | $42MM | $966MM | 6.9% | — | 5.4% | $12.4B | $2.73 | — |
| 2025.Q4 | $8.3B | 0.9% | 29.5% | 9.2% | $2.2B | $3.3B | $5.6B | 6.8% | — | 18.8% | $11.3B | $8.88 | 4.5 |
| italics below = DCF projection · 10yr Rev CAGR: 3.4% |
| 2026.Q4 | $8.2B | +-2.0% | 29.8% | 10.3% | $2.2B | $0MM | $2.2B | 6.9% | $2.0B | 19.3% | $11.3B | $11.03 | 5.8 |
| 2027.Q4 | $8.4B | +3.6% | 31.8% | 11.3% | $2.4B | $0MM | $2.4B | 7.1% | $2.1B | 21.1% | $11.3B | $12.06 | 5.3 |
| 2028.Q4 | $8.8B | +4.1% | 34.4% | 12.4% | $2.6B | $0MM | $2.6B | 7.3% | $2.2B | 23.4% | $11.3B | $13.38 | 4.8 |
| 2029.Q4 | $9.2B | +4.1% | 34.4% | 13.5% | $2.7B | $0MM | $2.7B | 7.4% | $2.1B | 24.0% | $11.3B | $13.76 | 4.6 |
| 2030.Q4 | $9.5B | +4.1% | 34.4% | 14.6% | $2.8B | $0MM | $2.8B | 7.6% | $2.0B | 24.7% | $11.3B | $14.14 | 4.5 |
|
| Term. Yr+ | $12.1B | 4.1% | 24.3% | 20.0% | $2.4B | −$452MM | $1.9B | 8.6% | $20.2B | 21.4% | — | — | — |
Active scenario IV: $204 (+220.9% vs market)